
Said Dermime
Senior Scientist and Director of the Translational Cancer Research Facility at Hamad Medical Corporation
About
Said Dermime is a leading expert in cancer immunology and translational research, with over three decades of experience bridging laboratory discoveries and clinical applications. As Senior Scientist and Director of the Translational Cancer Research Facility at Hamad Medical Corporation, he oversees multidisciplinary programs focused on developing innovative cancer therapies, vaccines, and diagnostic tools. His research has uncovered mechanisms of treatment resistance in leukemia, highlighted the role of PD-L1 in immune evasion, and advanced targeted immunotherapies, positioning him at the forefront of the global effort to translate scientific breakthroughs into meaningful patient outcomes.
